Viewing StudyNCT00051051



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00051051
Status: COMPLETED
Last Update Posted: 2007-05-04
First Post: 2003-01-02

Brief Title: A Phase II Study of CI-1033 in Treating Patients With Metastatic Stage IV Breast Cancer
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-12
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2005-05
Completion Date Type: ACTUAL
First Submit Date: 2003-01-02
First Submit QC Date: January 2 2003
Study First Post Date: 2003-01-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2007-05-03
Last Update Post Date: 2007-05-04
Last Update Post Date Type: ESTIMATED